(11210280), A. S., (18550873), A. M. A., (18550876), F. J., (1754095), S. B., (4545583), R. N., (1663198), S. B., . . . (17443947), S. M. A. (2020). Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application.
Chicago Style (17th ed.) Citation(11210280), Afsaneh Sadremomtaz, Ameena M. Ali (18550873), Foroozan Jouyandeh (18550876), Saeed Balalaie (1754095), Razieh Navari (4545583), Sylvain Broussy (1663198), Kamran Mansouri (2933658), Matthew R. Groves (8861588), and S. Mohsen Asghari (17443947). Molecular Docking, Synthesis and Biological Evaluation of Vascular Endothelial Growth Factor (VEGF) B Based Peptide as Antiangiogenic Agent Targeting the Second Domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for Anticancer Application. 2020.
MLA (9th ed.) Citation(11210280), Afsaneh Sadremomtaz, et al. Molecular Docking, Synthesis and Biological Evaluation of Vascular Endothelial Growth Factor (VEGF) B Based Peptide as Antiangiogenic Agent Targeting the Second Domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for Anticancer Application. 2020.